Tim Tarver is a dynamic technology leader whose career spans artificial intelligence, cybersecurity, full-stack software engineering, and data science, with a proven ability to align technical innovation with strategic business goals. Currently contributing to AI model development at Outlier AI and leading machine learning initiatives at Flomad Labs, Tim combines deep hands-on expertise with a visionary approach to emerging technologies. His academic background includes advanced degrees in Mathematics, Information Systems, and Data Science, along with specialized training from MIT, IBM, Google, and DeepLearning.AI. With certifications in encryption, network security, and Python programming, Tim brings a powerful blend of technical acumen and leadership to every endeavor. As a board candidate, he offers forward-thinking insight, cross-disciplinary expertise, and a steadfast commitment to ethical innovation and lifelong learning.

Eric Trac is a visionary healthcare investor and biopharmaceutical strategist with a unique blend of medical expertise and financial acumen, driving transformative growth in the healthcare sector. As a Senior Analyst & Director at Sarissa Capital Management, he leads activist investment strategies, evaluates public and private market opportunities, and serves as a board director at Lyndra Therapeutics. With a background in venture capital at Vida Ventures and Vivo Capital, he has played a pivotal role in high-impact transactions, including Bayer’s $4 billion acquisition of AskBio and Centessa Pharmaceuticals’ $250 million Series A. Trac’s deep scientific foundation stems from his MD and MBA from Stanford University and his research in biotechnology at MIT, where he graduated in the top 8% of his class. Recognized as one of *Business Insider’s* “14 Most Impressive Students at MIT,” he continues to leverage his expertise in medicine and finance to drive innovation, maximize shareholder value, and advance the future of biopharmaceuticals.

Steve Gordon is a seasoned executive, entrepreneur, and innovator with over 40 years of leadership experience across manufacturing, consumer products, scientific instruments, and food & beverage industries. A proven expert in product development, venture capital, mergers & acquisitions, and automation, he has successfully founded, scaled, and exited multiple companies, including leading Intelligent Bio-Systems to a successful acquisition by Qiagen. Currently serving as CEO of Swish Hoop, Steve continues to drive innovation with patented sports technology solutions. With over 50 patents, extensive board experience, and a passion for mentoring and strategic growth, he is actively seeking advisory and board roles where he can apply his expertise to help organizations navigate innovation, commercialization, and market expansion.